Immuneering (IMRX) Revenue (2020 - 2022)
Powered by 
Analysis
Immuneering (IMRX) Revenue (2020 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 455.00 |
| Sep 30, 2022 | 38,380.00 |
| Jun 30, 2022 | 94,419.00 |
| Mar 31, 2022 | 183,698.00 |
| Dec 31, 2021 | 189,591.00 |
| Sep 30, 2021 | 482,130.00 |
| Jun 30, 2021 | 660,040.00 |
| Mar 31, 2021 | 748,200.00 |
| Dec 31, 2020 | 665,080.00 |
| Sep 30, 2020 | 682,570.00 |
| Jun 30, 2020 | 480,835.00 |
API Access
Immuneering Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();